S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TVTX Travere Therapeutics Inc

19.68

0.65 (3.42%)

After Hours

Last Updated: 10:00:28

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics Inc News

Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Wednesday 13 November 2024 (2 hours ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 9 November 2024 (4 days ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 9 November 2024 (4 days ago) • Edgar (US Regulatory)

Travere Therapeutics Announces Pricing of Public Offering of Common Stock
Friday 8 November 2024 (5 days ago) • GlobeNewswire Inc.

Travere Therapeutics Announces Proposed Public Offering of Common Stock
Friday 8 November 2024 (5 days ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 8 November 2024 (5 days ago) • Edgar (US Regulatory)

Travere Therapeutics to Present at Upcoming Investor Conferences
Tuesday 5 November 2024 (1 week ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 31 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 31 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 31 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Travere Therapeutics Reports Third Quarter 2024 Financial Results
Thursday 31 October 2024 (2 weeks ago) • GlobeNewswire Inc.

Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024
Saturday 26 October 2024 (3 weeks ago) • GlobeNewswire Inc.

More Travere Therapeutics Inc News Articles

National Australia Bank

S&P ASX 300 Metals and M...

Australia And New Zealan...

Gold vs US Dollar

Invesco QQQ Trust Series 1

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions